Loading…
Cencora, Inc. is projected to rise to $312.27 by 2027, a +17% move from its current price of $267.01. COR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $263.23 | $267.06 | $270.94 | +0.02% |
| May 30 | $261.71 | $267.10 | $272.61 | +0.03% |
| May 31 | $260.56 | $267.15 | $273.90 | +0.05% |
| Jun 1 | $259.60 | $267.19 | $275.01 | +0.07% |
| Jun 2 | $258.76 | $267.24 | $276.00 | +0.09% |
| Jun 3 | $258.01 | $267.29 | $276.90 | +0.10% |
| Jun 4 | $257.32 | $267.33 | $277.73 | +0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $257.32 | $267.33 | $277.73 | +0.12% |
| Week 2 | $253.59 | $267.65 | $282.49 | +0.24% |
| Week 3 | $250.84 | $267.97 | $286.28 | +0.36% |
| Week 4 | $248.58 | $268.30 | $289.57 | +0.48% |
| Week 5 | $246.65 | $268.62 | $292.54 | +0.60% |
| Week 6 | $244.94 | $268.94 | $295.29 | +0.72% |
| Week 7 | $243.41 | $269.26 | $297.87 | +0.84% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. Its U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.
Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry.
The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
COR is the stock ticker for Cencora, Inc. and represents a healthcare company focused on pharmaceutical sourcing and distribution. The current price shown is $274.91, reflecting recent market activity.
The market capitalization stands at $53.49B, and the stock is ranked 298 by market capitalization. These metrics position COR among mid-to-large cap healthcare distributors within the broader market space.
Looking ahead, the year-by-year forecast shows the average price evolving over time, beginning at $274.91 in 2026 and rising to $414.80 by 2030, with substantial upside through 2050 (average $2,003.84). The forecast includes considerable upside potential, with a max forecast of $3,279.09 by 2050.
Overall, the outlook suggests a bullish long-run trajectory, though near-term results may vary as indicated by the explicit year-by-year figures.
A major floor 22.2% below — a decisive break under it would weaken the trend.
The nearest floor, 5.3% below — buyers have tended to step in here.
The nearest ceiling, 22.7% above — a clean break opens room to run.
A major ceiling 39.6% above — clearing it would confirm fresh momentum.
Key COR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of COR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $268.58 | Sell | $268.15 | Sell |
| MA 10 | $264.54 | Buy | $268.25 | Sell |
| MA 20 | $273.43 | Sell | $275.39 | Sell |
| MA 50 | $301.18 | Sell | $297.23 | Sell |
| MA 100 | $328.10 | Sell | $313.57 | Sell |
| MA 200 | $326.35 | Sell | $315.55 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.92 | Neutral |
| Stoch RSI (14) | 80.27 | Sell |
| CCI (20) | -25.56 | Neutral |
| Williams %R (14) | -41.04 | Info |
| MACD (12,26,9) | 2.41 | Buy |
| ROC (12) | 2.27 | Buy |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 58.96 | Neutral |
| TRIX (15) | -0.69 | Sell |
| Awesome (5,34) | -22.71 | Sell |
| Ultimate (7,14,28) | 60.74 | Neutral |
| Momentum (10) | 6.08 | Buy |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 272.56 | Sell |
| ADX (14) | 31.41 | Sell |
| ATR (14) | 4.96 | Info |
In the near term, the sentiment is bullish, with the 30-day range spanning from $249.65 to $302.73. The RSI(14) stands at 40, and the price currently sits below key moving averages: the SMA50 is $304.34 and the SMA200 is $326.48.
A defined support level sits at $252.74, while a resistance level is noted at $327.56. These levels, along with the 30-day range, provide a framework for potential fluctuations in the coming weeks and help define near-term trading expectations.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $252.74 | $267.01 | $371.00 | 0% | Neutral | |
| $255.10 | $312.27 | $400.11 | +17% | Neutral | |
| $274.85 | $342.58 | $450.41 | +28% | Bullish | |
| $295.62 | $374.06 | $502.03 | +40% | Bullish | |
| $303.38 | $388.99 | $531.31 | +46% | Bullish | |
| $355.78 | $461.69 | $640.44 | +73% | Bullish | |
| $402.79 | $528.53 | $743.47 | +98% | Bullish | |
| $432.49 | $573.44 | $816.97 | +115% | Bullish | |
| $482.57 | $646.17 | $931.50 | +142% | Bullish | |
| $481.77 | $651.16 | $949.06 | +144% | Bullish | |
| $713.39 | $1,005.52 | $1,535.34 | +277% | Bullish | |
| $1,191.13 | $1,800.30 | $2,945.77 | +574% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $252.74 | $267.01 | $311.96 | +0.00% |
| June 2026 | $226.92 | $264.71 | $314.79 | -0.86% |
| July 2026 | $231.17 | $271.22 | $325.58 | +2.46% |
| August 2026 | $237.01 | $279.33 | $337.76 | +2.99% |
| September 2026 | $236.97 | $280.32 | $340.97 | +0.36% |
| October 2026 | $239.82 | $284.66 | $348.11 | +1.55% |
| November 2026 | $248.46 | $295.80 | $363.44 | +3.91% |
| December 2026 | $251.78 | $300.61 | $371.00 | +1.63% |
Click any year to see its month-by-month COR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Cencora, Inc.'s 2026 outlook centres on $267.01, within a $252.74 to $371.00 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, COR could reach as high as $400.11, with a base case around $312.27 and support toward $255.10 — roughly +17% from $267.01. Price action looks broadly range-bound.
Expect COR to range from $274.85 to $450.41 through 2028. The $342.58 average target implies a +28% move from current prices. That is up +10% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The COR price prediction for 2029 points to an average of $374.06 (low $295.62, high $502.03) — a potential gain of +40% on today's $267.01. Momentum favours further upside here.
In 2030, COR is projected to trade between $303.38 and $531.31, averaging $388.99 — a potential gain of +46% from today's $267.01. That is up +4% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Cencora, Inc.'s 2031 outlook centres on $461.69, within a $355.78 to $640.44 range. That is up +19% on the projected 2030 average. That marks a +73% change versus current levels. Momentum favours further upside here.
By 2032, COR could reach as high as $743.47, with a base case around $528.53 and support toward $402.79 — roughly +98% from $267.01. Buyers look set to stay in control over this stretch.
Expect COR to range from $432.49 to $816.97 through 2033. The $573.44 average target implies a +115% move from current prices. That is up +8% on the projected 2032 average. Momentum favours further upside here.
The COR price prediction for 2034 points to an average of $646.17 (low $482.57, high $931.50) — a potential gain of +142% on today's $267.01. Buyers look set to stay in control over this stretch.
In 2035, COR is projected to trade between $481.77 and $949.06, averaging $651.16 — a potential gain of +144% from today's $267.01. That is up +1% on the projected 2034 average. Momentum favours further upside here.
Cencora, Inc.'s 2040 outlook centres on $1,005.52, within a $713.39 to $1,535.34 range. That is up +54% on the projected 2035 average. That marks a +277% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, COR could reach as high as $2,945.77, with a base case around $1,800.30 and support toward $1,191.13 — roughly +574% from $267.01. Momentum favours further upside here.
Investing $1,000 in COR today (≈ 3.745178 COR) could be worth
$6,742.43
+$5,742.43 (+574%) by 2050 · US Dollar
Based on the average projected COR price of $1,800.3 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CORwould be worth at today's price.
$1,000 invested in COR on May 27, 2025 (≈ 3.408432 COR) would be worth
$910.09
-$89.91 (-9.0%) today · 0.91× · US Dollar
Based on a COR entry price of $293.39 vs. today's $267.01.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $264.75 | $1,008.54 | +0.9% |
| 1 month ago | $310.16 | $860.88 | -13.9% |
| 3 months ago | $366.65 | $728.24 | -27.2% |
| 6 months ago | $368.93 | $723.74 | -27.6% |
| 1 year ago | $293.39 | $910.09 | -9.0% |
| All time (5.0y) ago | $114.32 | $2,335.64 | +133.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our COR forecast.
Our base-case forecast reaches $530.00 around 2033.
Implied market cap at $530.00: $103.12B
The multi-year forecast paints a steadily rising trajectory for COR, with the average price advancing from $274.91 in 2026 to $414.80 in 2030 and $2,003.84 by 2050. The corresponding ROI figures begin at 0% in 2026, rise to 50.9% by 2030, then accelerate to 81% (2031), 107.1% (2032), 125.7% (2033), 155.7% (2034), and 156.7% (2035).
The long-range outlook remains bullish across the horizon, with stronger averages and higher max values: by 2040 the average is $1,113.32 and the max forecast reaches $1,700.12 (ROI 305%). By 2050 the average is $2,003.84 and the max forecast extends to $3,279.09 (ROI 628.9%). These figures imply meaningful upside potential, but they are estimates and not guarantees.
Risks and uncertainties can affect actual performance and outcomes.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $414.80 with a minimum of $323.46 and a maximum of $566.69, and an expected ROI of 50.9% with a bullish sentiment.
Long-term forecasts show a bullish trajectory with rising averages: 2027 avg $325.28 (ROI 18.3%), 2028 avg $360.40 (ROI 31.1%), 2029 avg $395.01 (ROI 43.7%), and 2030 avg $414.80 (ROI 50.9%). The outlook continues to be bullish through 2050 (avg $2,003.84; max $3,279.09; ROI 628.9%), but these are estimates, not guarantees.
Yes. The forecast provides max values above $1,000: $1,013.49 by 2034 and $1,028.57 by 2035, with further upside to $1,700.12 by 2040 and $3,279.09 by 2050.
Current price is $274.91 and market capitalization is $53.49B. The stock is ranked 298.
The near-term setup is bullish with a 30-day range of $249.65 to $302.73. RSI(14) is 40, the SMA50 is $304.34, and the SMA200 is $326.48. Key support stands at $252.74 and resistance at $327.56.
Cencora, Inc. Community Discussion
0Share your Cencora, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.